Use of Monoclonal Antibodies in Immunocompromised Patients Hospitalized with Severe COVID-19: A Retrospective Multicenter Cohort.

Jorge Calderón-ParraPablo Guisado VascoRocío Montejano-SánchezVicente Estrada Guillermo Cuevas Tascón José AguarelesJosé ArribasMarta Erro-IribarrenMarina Calvo-SalvadorAna Fernández Cruz Antonio Ramos MartínezElena Muñez-Rubio

Published in: Journal of clinical medicine (2023)

Sotrovimab was safe and may be effective in its use for immunocompromised patients with severe COVID-19. More studies are needed to confirm these preliminary data.

Keyphrases

coronavirus disease
sars cov
end stage renal disease
newly diagnosed
early onset
prognostic factors
clinical trial
cross sectional
intensive care unit
big data
machine learning